Drug Information Association Logo
Thought Leaders

DIA 2015 51st Annual Meeting

DIA 2015 51st Annual Meeting

June 14-18, 2015
Washington, DC

Walter E. Washington Convention Center

facebook linked-in twitter youtube Flickr Instagram

GO Meeting Highlights

DIA 2015 51st Annual Meeting

Dear Colleague,

Mobilizing medical insight, discovery and invention to help patients is a team effort. Patients and their families expect that we will work collaboratively and use our collective skills to improve health – as efficiently and quickly as possible. No doubt, collaboration is a skill and a challenge. Honing that skill and exploring the challenge requires conversation and expression. The DIA 2015 51st Annual Meeting gathering in Washington, DC, is the perfect place to pursue our shared mission to improve health and well-being, and to learn how to be great partners in drug development from each other.

To that end, I am honored to serve as Program Co-Chair of the DIA 2015 51st Annual Meeting, alongside Dr. Christopher Austin, Director of the National Center for Advancing Translational Sciences (NCATS). Dr. Austin and I join together at a time when collaboration throughout the research and health care communities can accelerate the generation and implementation of innovations for patients.

The DIA 2015 51st Annual Meeting gives us a special place and time to connect with people and organizations with cutting-edge ideas to accelerate development of new therapies and explore and exchange ways to enhance health and well-being – from engaging with patients to applying information technologies that shift how we work with each other.  

By participating in the insightful and stimulating sessions offered this year, you will have unprecedented access to thought leaders from global and regional regulatory agencies and constituents in the pharmaceutical, biotechnology, and medical products industry in a collegial environment where improving health is the common goal.

The sessions are many and the topics thought provoking and informative. They include:

Disruptive Forces in Health Care Innovation: Where Are They Leading Us?
Breakthrough Medicines or Affordable Health Care: Do We Have to Choose?
Operationalizing the Pragmatic Clinical Trial: The Role of PCORI and the Pharmaceutical Industry
International Regulatory Convergence: Collaboration, Cooperation and Global Governance
The Future of Clinical Trial Data Sharing
An Insider’s View of Cooperation Between the EMA and CDER/FDA: Question Time

The DIA Annual Meeting is a forum – a community – for you to further build the skills necessary to pioneer new patient therapies in the 21st Century. Together with my DIA colleagues, I hope you will join us next month in Washington, DC. I look forward to meeting you.


Michael Rosenblatt, MD
Michael Rosenblatt, MD
Executive Vice President and Chief Medical Officer
Merck & Co. Inc.
DIA 2015 51st Annual Meeting Program Co-Chair

GO Onsite Final Program

DIA 2015 Final ProgramStart Planning Your Agenda Today!

Just released, the onsite final program is now available for you to start planning your schedule for the Annual Meeting. Even though registered attendees will get their own personal copy upon checking in with registration, take some time now to build your schedule, identify room locations and plan your day. Everything you need to know about DIA 2015 51st Annual Meeting can be found in the final program: Schedule At-A-Glance, Meeting Highlights, Networking Opportunities, Exhibiting Companies, Glossary of Terms and  Much More!

View Onsite Final Program

GO The Walking Gallery

The Walking Gallery

The Walking Gallery

Join us on Monday, June 15 from 4:00-6:00PM in the DIA Booth #1523 (Exhibit Hall) as we gather and welcome members of The Walking Gallery, a patient empowerment movement founded by Artist Regina Holliday.

Current Walking Gallery members interested in joining us at the Opening Reception can RSVP to Julie.Ho@diahome.org

DIA Annual Meeting Participants who are interested in joining The Walking Gallery as a walking member must contact Regina Holliday (via Facebook, Twitter, or LinkedIn) prior to the Annual Meeting Watch The Walking Gallery of Health Care

Watch The Walking Gallery of Health Care

GO About DIA 2015

The DIA 2015 51st Annual Meeting is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines come together each June all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

DIA 2015 51st Annual Meeting will:
  • Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care
  • Provide comprehensive coverage of the full development and life cycle management of process for all health care products
  • Offer a holistic and integrated approach to the development life cycle management of regulated health care products

DIA 2015 51st Annual Meeting provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

GO Call for Power Up! Presenters

Come join us on Wednesday, June 17 in room 152B for another inspirational session of Power Up! Presentations at the DIA 51st Annual Meeting and learn how your peer's passion has driven them to their successes.

Nine individuals will be sharing their distinctive experience/stories in five minutes with 20 slides; presentation titles are listed below:
  • From Medical Student to Patient to Patient Advocate
  • Re-orientating the Racing Brain
  • Flying Blind in a Hurricane: Why Pharma Must Think "Systems"
  • From Geek to Geek Chic: The Passion and Power of Science and Math
  • Try Law. Then Leave It. Like I did
  • I have to do what? Tales and Triumphs as a Clinical Study Participant
  • Seuss Consulting: Where It's Safe to Reveal Your Super Powers!
  • Living with Type III Mody Diabetes
  • Glass Ceiling or Stinkin' Thinkin'? An Application to Life Sciences of Sheryl Sandberg's Lean-In
Twitter#dia2015powerup #dia2015


View last year’s inaugural Power Up! session.

GO Registration Fees

How to Register
We offer four easy ways to register for the DIA 2015 51st Annual Meeting - Online, Phone, FAX or Mail.

Online Program
Sign-up online- it's the quickest way to register.
+1.888.257.6457 (Mon-Fri, 8AM-5PM EDT)
Registration form (PDF) to +1.215.442.6199
Drug Information Association
P.O. Box 95000-1240
Philadelphia, PA 19195-1240, USA
(Note: Checks must be drawn on U.S. bank)
Need to justify your attendance to your employer? Download the attendance justification letter.

Group Registration Available!
Register 10 individuals and receive a complimentary registration. Note: Reduced registration fees do not qualify for group registration. Contact CustomerService@DIAHome.org for details.

Registration Fees


Member Academia
Member Government
Member Standard
One-Day Member


NonMember Academia
NonMember Government
NonMember Standard
One-Day Nonmember

Registration Fees for Additional Offerings

#20: The Sunshine Act: Understanding the Essentials - Standard Rate
#21: Leadership: How to Organize and Lead People - Standard Rate
#22: Successful Drug Development: Best Practices - Standard Rate
#23: How to Prepare for an FDA Inspection - Standard Rate
#25: Signal Detection: Identifying and Managing Safety Signals - Standard Rate
#30: Japan Regulatory Environment: Overview - Standard Rate
#31: Preparing for a US FDA Advisory Committee Meeting - Standard Rate
# 32: Influencing Culture, Avoiding Bureaucracy - Standard Rate
#33: Large-Scale Regulatory Functional Outsourcin - Standard Rate
#34: Preparation of Risk Evaluation and Mitigation - Standard Rate
#35: Ethical Issues in Clinical Trials - Standard Rate
#40: Analysis of Safety Data from Clinical Trials - Standard Rate
#41: Quality Oversight of CROs-Clinical Vendors - Standard Rate
#42: Fundamentals of ANDA Submissions - Standard Rate
#43: Clinical Statistics for Nonstatisticians - Standard Rate
#44: Risk Management and Safety Communication - Standard Rate
#45: The Good Pharmacovigilance Practices in the EU - Standard Rate